サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：臨床試験管理サービスの世界市場 - 産業規模、シェア、動向、機会、予測：サービスタイプ別、業界別、適応症別、企業別、地域別（2017年～2027年）
市場調査レポート
商品コード
1166579

臨床試験管理サービスの世界市場 - 産業規模、シェア、動向、機会、予測：サービスタイプ別、業界別、適応症別、企業別、地域別（2017年～2027年）

Clinical Trials Management Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Service Type, By Industry, By Indication, By Company and By Region
出版日: | 発行: TechSci Research | ページ情報: 英文 113 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

臨床試験管理サービスの世界市場 - 産業規模、シェア、動向、機会、予測：サービスタイプ別、業界別、適応症別、企業別、地域別（2017年～2027年）
出版日: 2022年12月01日
発行: TechSci Research
ページ情報: 英文 113 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の臨床試験管理サービス市場は、2023年から2027年の予測期間中に目覚ましい成長を遂げると予測されています。

主な要因は、さまざまな疾患の発生率の増加、個別化医療に対する需要の高まり、技術の広範な開発が含まれており、市場の成長を推進しています。市場の成長を支えるその他の要因としては、広範な研究開発、さまざまな生命関連疾患の有病率、多数の臨床試験と研究調査、予防接種と医薬品に対する膨大な需要、人口高齢化の進展、製薬会社やバイオテクノロジー企業による研究開発活動への投資の増加などが挙げられます。また、慢性疾患やその他の生活習慣病が増加しているため、世界的に市場の成長が加速しています。

当レポートでは、世界の臨床試験管理サービス市場について調査し、セグメント別の分析、市場力学、企業プロファイルなどの情報を提供しています。

目次

第1章 サービスタイプ概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の臨床試験管理サービス市場に対するCOVID-19の影響

第5章 VOC (顧客の声)

第6章 世界の臨床試験管理サービス市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • サービスタイプ別（臨床試験モニタリング、承認申請、臨床試験データ管理、施設管理・モニタリング、その他）
    • 業界別（医療機器 v/s 医薬品）
    • 適応症別（免疫学、血液学、腫瘍学、神経学、その他）
    • 地域別
    • 企業別（2021年）
  • 市場マップ

第7章 北米の臨床試験管理サービス市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • サービスタイプ別
    • 業界別
    • 適応症別
    • 国別
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第8章 欧州の臨床試験管理サービス市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • サービスタイプ別
    • 業界別
    • 適応症別
    • 国別
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋の臨床試験管理サービス市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • サービスタイプ別
    • 業界別
    • 適応症別
    • 国別
  • アジア太平洋：国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第10章 南米の臨床試験管理サービス市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • サービスタイプ別
    • 業界別
    • 適応症別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカの臨床試験管理サービス市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • サービスタイプ別
    • 業界別
    • 適応症別
    • 国別
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場の動向と発展

第14章 競合情勢

  • Laboratory Corporation of America Holdings
  • SGS Health Sciences
  • IQVIA, Inc.
  • Syneous Health, Inc.
  • Atlantic Research Group
  • ICON PLC
  • Charles River Laboratories International, Inc.
  • Medpace Holdings, Inc.

第15章 戦略的提言

目次
Product Code: 12996

The global clinical trials management services market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of various diseases, upsurge demand for personalized medicines, and extensive development in technology, are curbing the market's growth. A clinical trial is a process in which several experiments or studies are performed on animals and humans to examine the results. Clinical trials are divided into two types that is observational studies and interventional trials. The other factors supporting the market's growth are, the extensive research and development, prevalence of various life-related diseases, large number of clinical trials and research studies, huge demand for vaccinations and medications, the growing aging population, and rise in investments by pharmaceutical and biotechnology companies in research and development activities.

Increasing Prevalence of Chronic and Lifestyle-Related Disorders

The growing occurrences of chronic diseases and other lifestyle-based diseases among population are augmenting the growth of the market, globally. Nowadays, people are opting for unhealthy choices such as tobacco, smoking, consumption of junk foods and others, due to which they suffer from various chronic diseases such as diabetes, heart strokes, hypertension, blood pressure and other. As per the national health survey, between 2017-2018, approximately 28.8% of adults in the UAE have high blood pressure. Owing to the increasing prevalence of these chronic diseases and growing demand for effective treatment methods, the surge in demand for development of innovative drugs is propelling the growth of the market, globally.

Rise in R&D Activities

Rising research and development activities for novel and personalized medications are propelling the growth of the market. Increasing investments in R&D activities such as by governments and key market players are strengthening the growth of the market. For instance, according to WHO, in 2020, 147,213 trials took place in the United States, then 23,051 trials in China and 13,481 in Japan.

Growing Demand for Precision Medicines

Growing prominence of specialized medicines is one of the primary factors, supporting the growth of the market. The surging demand for personalized medicines is due to their efficiency to treat unique, yet complex diseases. Doctors, researchers, and pharmaceutical firms are using precision medicine to develop new drugs and disease therapies, which surge the demand for clinical trial management services. For instance, in 2020, according to scope and significance of progress report, specialized medicines reported for about 39 percent of the total FDA-approved new drugs in the year.

Technological Advancements

Rapid advancements in tools and techniques are curbing the growth of the market. The increasing adoption of advanced technology such as AI, cloud based clinical trials, and machine learning in healthcare sector is driving the growth of the market. For instance, in South Korea, Asan Medical Center (AMC) has developed a new system, capable of handling clinical trial image data from group to extraction. This is expected to be a major revolution in CTM systems, as this could make clinical trials more effective and speedier than ever before. Similarly, as per the Veeva Unified Clinical Operations Survey, CROs are making major advancements to speed up and modernize clinical trials.

Market Segmentation

The global clinical trials management services market is segmented into service type, industry, indication, and company. Based on service type, the market is segmented into clinical trial monitoring, regulatory submissions, clinical trial data management, site management & monitoring, and others. Based on industry, the market is segmented into medical devices, and pharmaceuticals. Based on indication, the market is divided into immunology, hematology, oncology, neurology, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising occurrences in chronic diseases and extensive technology development in the country.

Market Players

Laboratory Corporation of America Holdings, SGS Health Sciences, IQVIA, Inc., Syneous Health, Inc., Atlantic Research Group, ICON PLC, Charles River Laboratories International, Inc., and Medpace Holdings, Inc. are some of the leading companies operating in the market.

Report Scope:

In this report, global clinical trials management services market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Clinical Trials Management Services Market, By Service Type:

Clinical Trial Monitoring

Regulatory Submissions

Clinical Trial Data Management

Site Management & Monitoring

Others

  • Clinical Trials Management Services Market, By Industry:

Medical Devices

Pharmaceuticals

  • Clinical Trials Management Services Market, By Indication:

Immunology

Hematology

Oncology

Neurology

Others

  • Clinical Trials Management Services Market, By Region:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

Australia

South Korea

Europe & CIS

Germany

France

United Kingdom

Spain

Italy

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Clinical Trials Management Services Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Type Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Clinical Trials Management Services Market

5. Voice of Customer

6. Global Clinical Trials Management Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service Type (Clinical Trial Monitoring, Regulatory Submissions, Clinical Trial Data Management, Site Management & Monitoring, Others)
    • 6.2.2. By Industry (Medical Devices v/s Pharmaceuticals)
    • 6.2.3. By Indication (Immunology, Hematology, Oncology, Neurology, Others)
    • 6.2.4. By Region
    • 6.2.5. By Company (2021)
  • 6.3. Market Map

7. North America Clinical Trials Management Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service Type
    • 7.2.2. By Industry
    • 7.2.3. By Indication
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Clinical Trials Management Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service Type
        • 7.3.1.2.2. By Industry
        • 7.3.1.2.3. By Indication
    • 7.3.2. Canada Clinical Trials Management Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service Type
        • 7.3.2.2.2. By Industry
        • 7.3.2.2.3. By Indication
    • 7.3.3. Mexico Clinical Trials Management Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service Type
        • 7.3.3.2.2. By Industry
        • 7.3.3.2.3. By Indication

8. Europe Clinical Trials Management Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service Type
    • 8.2.2. By Industry
    • 8.2.3. By Indication
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Clinical Trials Management Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service Type
        • 8.3.1.2.2. By Industry
        • 8.3.1.2.3. By Indication
    • 8.3.2. Germany Clinical Trials Management Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service Type
        • 8.3.2.2.2. By Industry
        • 8.3.2.2.3. By Indication
    • 8.3.3. United Kingdom Clinical Trials Management Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service Type
        • 8.3.3.2.2. By Industry
        • 8.3.3.2.3. By Indication
    • 8.3.4. Italy Clinical Trials Management Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service Type
        • 8.3.4.2.2. By Industry
        • 8.3.4.2.3. By Indication
    • 8.3.5. Spain Clinical Trials Management Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service Type
        • 8.3.5.2.2. By Industry
        • 8.3.5.2.3. By Indication

9. Asia-Pacific Clinical Trials Management Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service Type
    • 9.2.2. By Industry
    • 9.2.3. By Indication
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Clinical Trials Management Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service Type
        • 9.3.1.2.2. By Industry
        • 9.3.1.2.3. By Indication
    • 9.3.2. India Clinical Trials Management Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service Type
        • 9.3.2.2.2. By Industry
        • 9.3.2.2.3. By Indication
    • 9.3.3. Japan Clinical Trials Management Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service Type
        • 9.3.3.2.2. By Industry
        • 9.3.3.2.3. By Indication
    • 9.3.4. South Korea Clinical Trials Management Services Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Service Type
        • 9.3.4.2.2. By Industry
        • 9.3.4.2.3. By Indication
    • 9.3.5. Australia Clinical Trials Management Services Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Service Type
        • 9.3.5.2.2. By Industry
        • 9.3.5.2.3. By Indication

10. South America Clinical Trials Management Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service Type
    • 10.2.2. By Industry
    • 10.2.3. By Indication
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Clinical Trials Management Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service Type
        • 10.3.1.2.2. By Industry
        • 10.3.1.2.3. By Indication
    • 10.3.2. Argentina Clinical Trials Management Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service Type
        • 10.3.2.2.2. By Industry
        • 10.3.2.2.3. By Indication
    • 10.3.3. Colombia Clinical Trials Management Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service Type
        • 10.3.3.2.2. By Industry
        • 10.3.3.2.3. By Indication

11. Middle East and Africa Clinical Trials Management Services Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Service Type
    • 11.2.2. By Industry
    • 11.2.3. By Indication
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Clinical Trials Management Services Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Service Type
        • 11.3.1.2.2. By Industry
        • 11.3.1.2.3. By Indication
    • 11.3.2. Saudi Arabia Clinical Trials Management Services Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Service Type
        • 11.3.2.2.2. By Industry
        • 11.3.2.2.3. By Indication
    • 11.3.3. UAE Clinical Trials Management Services Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Service Type
        • 11.3.3.2.2. By Industry
        • 11.3.3.2.3. By Indication

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Laboratory Corporation of America Holdings
  • 14.2. SGS Health Sciences
  • 14.3. IQVIA, Inc.
  • 14.4. Syneous Health, Inc.
  • 14.5. Atlantic Research Group
  • 14.6. ICON PLC
  • 14.7. Charles River Laboratories International, Inc.
  • 14.8. Medpace Holdings, Inc.

15. Strategic Recommendations